Efrat Kessler

Dr. Efrat Kessler

Maurice and Gabriela Goldschleger Eye Research Institute, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
EKEfrat Kessler
Efrat Kessler
MSMary Safrin
Mary Safrin
JGJean K. Gustin
Jean K. Gustin
DODennis E. Ohman
Dennis E. Ohman
Pseudomonas aeruginosa elastase and the LasA protease are synthesized as preproenzymes with long amino-terminal propeptides. The elastase propeptide is cleaved autocatalytically in the periplasm to form a transient, inactive elastase-propeptide complex. In contrast, the processing of proLasA does not involve autoproteolysis. In this study, we analyzed short-termP. aeruginosa cultures under conditions that minimize proteolysis and found that an elastase-propeptide complex is secreted, and then the propeptide is degraded extracellularly, apparently by elastase itself. LasA protease, on the other hand, was found to be secreted in its unprocessed 42-kDa proenzyme form. The processing of proLasA occurred extracellularly, and it involved the transient appearance of a 28-kDa intermediate and the respective 14-kDa LasA propeptide fragment. The processing of proLasA in P. aeruginosa strain FRD740, which does not express elastase, also proceeded via the 28-kDa intermediate, but the rate of processing was greatly reduced. This low rate of proLasA processing was further reduced when the activity of a secreted lysine-specific protease was blocked. Purified secreted proteases of P. aeruginosa(i.e. elastase, the lysine-specific protease, and alkaline proteinase) converted proLasA to the active enzyme. Processing by elastase and the lysine-specific enzyme, but not by alkaline proteinase, proceeded via the 28-kDa intermediate, and both were far more effective than alkaline proteinase in converting proLasA to the mature enzyme. We conclude that LasA protease and elastase are secreted with their propeptides, which are then degraded by secreted proteases of P. aeruginosa. In addition to their other functions, the propeptides may play a role in targeting their respective enzymes across the outer membrane.

29 March 2014
Verified
Book Chapter
Closed access
PDF file
EKEfrat Kessler
Efrat Kessler
MSMary Safrin
Mary Safrin

1 October 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TWTali Weiss
Tali Weiss
SRSylvie Ricard-Blum
Sylvie Ricard-Blum
LMLaura Moschcovich
Laura Moschcovich
EWEitan Wineman
Eitan Wineman
SMShlomit Mesilaty
Shlomit Mesilaty
EKEfrat Kessler
Efrat Kessler
Procollagen C-proteinase enhancer-1 (PCPE-1) is an extracellular matrix (ECM) glycoprotein that can stimulate procollagen processing by procollagen C-proteinases (PCPs) such as bone morphogenetic protein-1 (BMP-1). The PCPs can process additional extracellular protein precursors and play fundamental roles in developmental processes and assembly of the ECM. The stimulatory activity of PCPE-1 is restricted to the processing of fibrillar procollagens, suggesting PCPE-1 is a specific regulator of collagen deposition. PCPE-1 consists of two CUB domains that bind to the procollagen C-propeptides and are required for PCP enhancing activity, and one NTR domain that binds heparin. To understand the biological role of the NTR domain, we performed surface plasmon resonance (SPR) binding assays, cell attachment assays as well as immunofluorescence and activity assays, all indicating that the NTR domain can mediate PCPE-1 binding to cell surface heparan sulfate proteoglycans (HSPGs). The SPR data revealed binding affinities to heparin/HSPGs in the high nanomolar range and dependence on calcium. Both 3T3 mouse fibroblasts and human embryonic kidney cells (HEK-293) attached to PCPE-1, an interaction that was inhibited by heparin. Cell attachment was also inhibited by an NTR-specific antibody and the NTR fragment. Immunofluorescence analysis revealed that PCPE-Flag binds to mouse fibroblasts and heparin competes for this binding. Cell-associated PCPE-Flag stimulated procollagen processing by BMP-1 several fold. Our data suggest that through interaction with cell surface HSPGs, the NTR domain can anchor PCPE-1 to the cell membrane, permitting pericellular enhancement of PCP activity. This points to the cell surface as a physiological site of PCPE-1 action.

1 May 2004 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
IBIrina S. Barequet
Irina S. Barequet
GSGuy J. Ben Simon
Guy J. Ben Simon
MSMary Safrin
Mary Safrin
DODennis E. Ohman
Dennis E. Ohman
EKEfrat Kessler
Efrat Kessler
LasA protease is a staphylolytic endopeptidase secreted by Pseudomonas aeruginosa . We have examined the effectiveness of LasA protease in the treatment of staphylococcal keratitis caused by methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) isolates in a rabbit model. Keratitis was induced by intrastromal injection of the bacteria. The eyes were treated topically, and the efficacy of LasA protease was compared to those of lysostaphin (a staphylolytic protease secreted by Staphylococcus simulans ) and vancomycin. When treatment was initiated early (4 h) after infection, practically all of the MSSA- and MRSA-infected corneas were sterilized by LasA protease, and its efficacy in eradicating the bacteria was comparable to those of lysostaphin and vancomycin. By contrast, most of the control corneas were heavily infected, with median values of 4.5 × 10 6 (MSSA) and 5 × 10 5 (MRSA) CFU/cornea ( P < 0.001). When treatment was initiated late (10 h) after infection, LasA protease reduced the numbers of CFU in both MSSA- and MRSA-infected corneas by 3 to 4 orders of magnitude compared to the numbers of CFU for the controls (median values, 1,380 and 30 CFU/cornea, respectively, for the treated animals compared to 1.2 × 10 6 and 5 × 10 5 CFU/cornea for the respective controls [ P = 0.001]), and it was more effective than vancomycin in eradicating MRSA cells ( P = 0.02). In both the early- and the late-treatment protocols, the clinical scores for eyes treated with LasA protease were significantly lower than those for the eyes of the corresponding controls and comparable to those for the lysostaphin- and vancomycin-treated eyes. We conclude that LasA protease is effective in the treatment of experimental S. aureus keratitis in rabbits and may have potential for the treatment of disease in humans.

15 May 2001 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
LMLaura Moschcovich
Laura Moschcovich
SBSimonetta Bernocco
Simonetta Bernocco
BFBernard Font
Bernard Font
HRHadassah Rivkin
Hadassah Rivkin
DEDenise Eichenberger
Denise Eichenberger
EKEfrat Kessler
Efrat Kessler
Recombinant human procollagen C‐proteinase enhancer (rPCPE) was expressed using a baculovirus system and purified to homogeneity using a three‐step procedure including heparin affinity chromatography. Heparin binding was dependent on the C‐terminal netrin‐like domain. The recombinant protein was found to be active, increasing the activity of procollagen C‐proteinase/bone morphogenetic protein‐1 on type I procollagen in a manner comparable to the native protein. Enhancing activity was dependent on intact disulfide bonding within the protein. By circular dichroism, the observed secondary structure of rPCPE was consistent with the known three‐dimensional structures of proteins containing homologous domains.

1 December 2014 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
TWTali Weiss
Tali Weiss
MBMarina Brusel
Marina Brusel
PRPatricia Rousselle
Patricia Rousselle
EKEfrat Kessler
Efrat Kessler